Pharmaceutical Accountability Foundation

Home Tags AbbVie

Tag: AbbVie

The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to the substantive issues. The court instructed AbbVie to answer on the PAF subpoena by 22 January 2025. PAF is very proud of our principle case...
AbbVie's Humira pricing policy drained up to €1.2 billion from the Dutch healthcare system AMSTERDAM, NETHERLANDS: Today the Amsterdam District Court ruled that the lawsuit filed by the Pharmaceutical Accountability Foundation  (PAF) against drug manufacturer AbbVie may proceed to its merits. In February 2023, PAF filed a lawsuit against AbbVie, alleging...
AMSTERDAM, THE NETHERLANDS: The Pharmaceutical Accountability Foundation (PAF) today brought a lawsuit against pharmaceutical company AbbVie for unfair, excessive pricing practices on its blockbuster medicine Humira(adalimumab). AbbVie sold €2.3 billion worth of Humira in the Netherlands during its market monopoly (2004-2018). PAF calculated that AbbVie had overcharged the Dutch healthcare...